169 related articles for article (PubMed ID: 36841845)
1. Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients.
Nojiri Y; Nakamura M; Magara T; Yamamoto A; Ikumi K; Nakamura R; Nishida E; Haarmann-Stemmann T; Morita A
Sci Rep; 2023 Feb; 13(1):3280. PubMed ID: 36841845
[TBL] [Abstract][Full Text] [Related]
2. Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.
Mantel A; Carpenter-Mendini AB; Vanbuskirk JB; De Benedetto A; Beck LA; Pentland AP
J Invest Dermatol; 2012 Apr; 132(4):1103-10. PubMed ID: 22170488
[TBL] [Abstract][Full Text] [Related]
3. Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.
Karunasinghe N; Ambs S; Wang A; Tang W; Zhu S; Dorsey TH; Goudie M; Masters JG; Ferguson LR
PLoS One; 2018; 13(6):e0199122. PubMed ID: 29920533
[TBL] [Abstract][Full Text] [Related]
4. Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.
Karunasinghe N; Symes E; Gamage A; Wang A; Murray P; Zhu S; Goudie M; Masters J; Ferguson LR
PLoS One; 2019; 14(5):e0217373. PubMed ID: 31125365
[TBL] [Abstract][Full Text] [Related]
5. Instability of C154Y variant of aldo-keto reductase 1C3.
Endo S; Takada S; Honda RP; Müller K; Weishaupt JH; Andersen PM; Ludolph AC; Kamatari YO; Matsunaga T; Kuwata K; El-Kabbani O; Ikari A
Chem Biol Interact; 2017 Oct; 276():194-202. PubMed ID: 28025170
[TBL] [Abstract][Full Text] [Related]
6. Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review.
Karunasinghe N; Masters J; Flanagan JU; Ferguson LR
Curr Cancer Drug Targets; 2017; 17(7):603-616. PubMed ID: 28359237
[TBL] [Abstract][Full Text] [Related]
7. Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N; Zhu Y; Han DY; Lange K; Zhu S; Wang A; Ellett S; Masters J; Goudie M; Keogh J; Benjamin B; Holmes M; Ferguson LR
BMC Urol; 2016 Aug; 16(1):48. PubMed ID: 27485119
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response.
Vogeley C; Sondermann NC; Woeste S; Momin AA; Gilardino V; Hartung F; Heinen M; Maaß SK; Mescher M; Pollet M; Rolfes KM; Vogel CFA; Rossi A; Lang D; Arold ST; Nakamura M; Haarmann-Stemmann T
Environ Int; 2022 Jan; 158():106989. PubMed ID: 34991250
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells.
Yamashita N; Kanno Y; Saito N; Terai K; Sanada N; Kizu R; Hiruta N; Park Y; Bujo H; Nemoto K
Biochem Biophys Res Commun; 2019 Aug; 516(3):693-698. PubMed ID: 31253396
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Evaluation of the Reductase Activities of Human
Takano S; Fukami T; Ichida H; Suzuki K; Nakano M; Nakajima M
Drug Metab Dispos; 2023 Sep; 51(9):1188-1195. PubMed ID: 37344179
[TBL] [Abstract][Full Text] [Related]
11. Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.
Voon PJ; Yap HL; Ma CY; Lu F; Wong AL; Sapari NS; Soong R; Soh TI; Goh BC; Lee HS; Lee SC
Br J Clin Pharmacol; 2013 Jun; 75(6):1497-505. PubMed ID: 23116553
[TBL] [Abstract][Full Text] [Related]
12. Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment.
Novotná E; Büküm N; Hofman J; Flaxová M; Kouklíková E; Louvarová D; Wsól V
Biochem Pharmacol; 2018 Oct; 156():22-31. PubMed ID: 30077642
[TBL] [Abstract][Full Text] [Related]
13. Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile.
Novotná E; Büküm N; Hofman J; Flaxová M; Kouklíková E; Louvarová D; Wsól V
Arch Toxicol; 2018 Sep; 92(9):2845-2857. PubMed ID: 29992508
[TBL] [Abstract][Full Text] [Related]
14. Novel SNPs of WNK1 and AKR1C3 are associated with preeclampsia.
Sun CJ; Li L; Li X; Zhang WY; Liu XW
Gene; 2018 Aug; 668():27-32. PubMed ID: 29777907
[TBL] [Abstract][Full Text] [Related]
15. Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia.
Liu CY; Hsu YH; Pan PC; Wu MT; Ho CK; Su L; Xu X; Li Y; Christiani DC;
Carcinogenesis; 2008 May; 29(5):984-90. PubMed ID: 18339682
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
Figueroa JD; Malats N; García-Closas M; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Lan Q; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N
Carcinogenesis; 2008 Oct; 29(10):1955-62. PubMed ID: 18632753
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
Park S; Song CS; Lin CL; Jiang S; Osmulski PA; Wang CM; Marck BT; Matsumoto AM; Morrissey C; Gaczynska ME; Chen Y; Mostaghel EA; Chatterjee B
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31894239
[TBL] [Abstract][Full Text] [Related]
18. Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.
Mantel A; Carpenter-Mendini A; VanBuskirk J; Pentland AP
Exp Dermatol; 2014 Aug; 23(8):573-8. PubMed ID: 24917395
[TBL] [Abstract][Full Text] [Related]
19. Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer.
Byrns MC; Duan L; Lee SH; Blair IA; Penning TM
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):177-87. PubMed ID: 20036328
[TBL] [Abstract][Full Text] [Related]
20. Association of AKR1C3 Polymorphisms with Bladder Cancer.
Tiryakioglu NO; Tunali NE
Urol J; 2016 Apr; 13(2):2615-21. PubMed ID: 27085562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
